BrittanyLBychkovskyMD

PubMed

• TP53-associated early breast cancer: new observations from a large cohort.
  Renata L Sandoval, Michele Bottosso, Li Tianyu, Natalia Polidorio, Brittany L Bychkovsky, Benjamin Verret, Alessandra Gennari, Sophie Cahill, Maria Isabel Achatz, Oliv...> ;Journal of the National Cancer Institute. 2024 Apr 3
• Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
  Tarantino, P., Gupta, H., Hughes, M., Files, J., Strauss, S., Kirkner, G., Feeney, A., Li, Y., Garrido-Castro, A., Barroso-Sousa, R., Bychkovsky, B., DiLascio, S., Sho...> ;Nature Communications. 2023 Dec 14
• 1 citations
  Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
  Tarantino, P., Gupta, H., Hughes, M., Files, J., Strauss, S., Kirkner, G., Feeney, A., Li, Y., Garrido-Castro, A., Barroso-Sousa, R., Bychkovsky, B., DiLascio, S., Sho...> ;Nature Communications. 2023 Nov 18
• Breast Cancer Screening in High-risk Women During Pregnancy and Lactation.
  Leah H Portnow, Lauren C Snider, Kimberly E Bolivar, Brittany L Bychkovsky, Margaret R Klehm, Eren D Yeh, Eva C Gombos, Sona A Chikarmane> ;Journal of Breast Imaging. 2023 Sep 22
• Endometrial Cancer Risk Among Germline/Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps.
  Kimia Sorouri, Filipa Lynce, Colleen M Feltmate, Michelle R Davis, Michael G Muto, Panagiotis A Konstantinopoulos, Elizabeth H Stover, Allison W Kurian, Sarah J Hill, ...> ;JCO Precision Oncology. 2023 Sep 1
• Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study.
  Claire B King, Brittany L Bychkovsky, Erica T Warner, Tari A King, Rachel A Freedman, Elizabeth A Mittendorf, Fisher Katlin, Anna Revette, Danielle M Crookes, Neil Man...> ;BMC Primary Care. 2023 Aug 25
• 2 citations
  Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.
  Stefania Morganti, Brittany L Bychkovsky, Philip D Poorvu, Ana C Garrido-Castro, Anna Weiss, Caroline C Block, Ann H Partridge, Giuseppe Curigliano, Nadine M Tung, Nan...> ;The Oncologist. 2023 Jul 5
• Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception.
  Brittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, Carrie Horton, Parichehr Hemyari, Holly LaDuca, Judy E Garber, Rochelle Scheib, Huma Q Rana> ;Breast Cancer Research and Treatment. 2023 Jul 1
• 1 citations
  Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
  Brittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, Carrie Horton, Parichehr Hemyari, Holly LaDuca, Judy E Garber, Rochelle Scheib, Huma Q Rana> ;Breast Cancer Research and Treatment. 2023 Jul 1
• ASO Visual Abstract: Screening MRI Does Not Increase Cancer Detection or Result in Earlier Stage at Diagnosis in Patients with High-Risk Breast Lesions-A Propensity Sc...
  Alison Laws, Fisher Katlin, Marybeth Hans, Mary Graichen, Olga Kantor, Christina Minami, Brittany L Bychkovsky, Lydia E Pace, Rochelle Scheib, Judy E Garber, Tari A King> ;Annals of Surgical Oncology. 2023 Jan 1
• 6 citations
  Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis.
  Alison Laws, Fisher Katlin, Marybeth Hans, Mary Graichen, Olga Kantor, Christina Minami, Brittany L Bychkovsky, Lydia E Pace, Rochelle Scheib, Judy E Garber, Tari A King> ;Annals of Surgical Oncology. 2023 Jan 1
• 18 citations
  Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2.
  Brittany L Bychkovsky, Nihat B Agaoglu, Carolyn Horton, Jing Zhou, Amal Yussuf, Parichehr Hemyari, Marcy E Richardson, Colin Young, Holly LaDuca, Deborah L McGuinness,...> ;JAMA Oncology. 2022 Nov 1
• 7 citations
  Call for action: expanding global access to hereditary cancer genetic testing.
  Brittany Bychkovsky, Huma Q Rana, Foluso Ademuyiwa, Jennifer Plichta, Karen Anderson, Angélica Nogueira-Rodrigues, Cesar A Santa-Maria, Lan G Coffman, Carol Marquez, A...> ;The Lancet. Oncology. 2022 Sep 1
• 8 citations
  Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen.
  Brittany Bychkovsky, Alison Laws, Fisher Katlin, Marybeth Hans, Mary Knust Graichen, Lydia E Pace, Rochelle Scheib, Judy E Garber, Tari A King> ;Breast Cancer Research and Treatment. 2022 Jun 1
• 6 citations
  Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program.
  Brittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, Nabihah Tayob, Joanna Mercado, Israel Gomy, Anu Chittenden, Sarah Kane, Samantha Stokes, Melissa E Hughes, Ji Seok K...> ;Clinical Cancer Research. 2022 Jun 1
• 6 citations
  Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
  Brittany L Bychkovsky, Min-Tzu Lo, Amal Yussuf, Carrie Horton, Marcy Richardson, Holly LaDuca, Judy E Garber, Huma Q Rana> ;Cancer. 2022 Mar 15
• 1 citations
  A Tribute to Dr Larissa Lee.
  Brittany L. Bychkovsky, Tian Zhang, Andrew Wang, Ronald C. Chen, Jairam R Eswara> ;Practical Radiation Oncology. 2021 Nov 17
• 30 citations
  Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward.
  Carlos Barrios, Gustavo Werutsky, Alejandro Mohar, Ana S. Ferrigno, Bettina Müller, Brittany L. Bychkovsky, Carlos José Castro E, Claudia Uribe, Cynthia Villarreal-Gar...> ;The Lancet. Oncology. 2021 Nov 1
• 24 citations
  Genomic Characterization of de novo Metastatic Breast Cancer
  Ana C. Garrido-Castro, Liam F. Spurr, Melissa E. Hughes, Yvonne Y. Li, Andrew D. Cherniack, Priti Kumari, Maxwell R. Lloyd, Brittany L. Bychkovsky, Romualdo Barroso-So...> ;Clinical Cancer Research. 2021 Feb 15
• 105 citations
  Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer
  Romualdo Barroso-Sousa, Tanya Keenan, Sonia Pernas, Pedro Exman, Esha Jain, Ana C. Garrido-Castro, Melissa E. Hughes, Brittany L. Bychkovsky, Renato Umeton, Janet File...> ;Clinical Cancer Research. 2020 Feb 4
• 6 citations
  Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials
  Pedro Exman, Ana C. Garrido-Castro, Melissa E. Hughes, Rachel A. Freedman, Tianyu Li, Lorenzo Trippa, Brittany L. Bychkovsky, Romualdo Barroso-Sousa, Simona Di Lascio,...> ;JCO Precision Oncology. 2019 Nov 15
• 4 citations
  Are rare cancer survivors at elevated risk of subsequent new cancers
  Dianne M. Finkelstein, Nora Horick, Ritesh Ramchandani, Kristina L. Boyd, Huma Q. Rana, Brittany L. Bychkovsky> ;BMC Cancer. 2019 Feb 21
• 5 citations
  Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk.
  Anna Weiss, Samantha Grossmith, Danielle Cutts, Sage A. Mikami, Johanna A. Suskin, Mary Knust Graichen, Negui Arilis Rojas, Lydia E. Pace, Eileen Joyce, Esther Rhei, R...> ;Breast Cancer Research and Treatment. 2019 Jan 21
• 24 citations
  Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Me...
  M Debiasi, Carisi Anne Polanczyk, Patricia Klarmann Ziegelmann, Carlos H. Barrios, Hongyuan Cao, James J. Dignam, Paul E. Goss, Brittany L. Bychkovsky, Dianne M. Finke...> ;Frontiers in Oncology. 2018 May 22
• 12 citations
  Cancer Pathology Turnaround Time at Queen Elizabeth Central Hospital, the Largest Referral Center in Malawi for Oncology Patients.
  Leo Masamba, Petani Mtonga, Linda Kalilani Phiri, Brittany L. Bychkovsky> ;Journal of Global Oncology. 2017 Apr 11
• Join now to see all